Last reviewed · How we verify

NCT04270253

End-range Mobilization on Knee Osteoarthritis

Completed NA Last updated 3 November 2020
What this trial tests

NA trial testing Conservative therapy in Osteo Arthritis Knee in 30 participants. Completed in 12 May 2020.

Timeline
12 February 2020
Primary endpoint
12 February 2020
12 May 2020

Quick facts

Lead sponsorUniversity of Pecs
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment30
Start date12 February 2020
Primary completion12 February 2020
Estimated completion12 May 2020
Sites1 location across Hungary

Drugs / interventions tested

Conditions studied

Sponsor

University of Pecs

Who can join

Adults 60 to 90, any sex, with Osteo Arthritis Knee. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Different manual therapy techniques and conservative therapy have been used separately for alleviation of pain and improvement of physical function in patients with knee osteoarthritis (KOA). However, no study has reported the effect of combination of these treatment modalities in the management of KOA. The aim of this study was to investigate the effect of end-range mobilization added to conservative therapy versus conservative therapy alone on decrease of pain and improvement of functional status in KOA.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Clinical Effect of End-range Maitland Mobilization in the Management of Knee Osteoarthritis - A Pilot Study.
    Pozsgai M, Kövesdi E, Németh B, Kiss I, et al · · 2021 · cited 2× · PMID 33910850 · DOI 10.21873/invivo.12425

Verify or expand the search:

Other trials of Conservative therapy

Trials testing the same drug.

Other recruiting trials for Osteo Arthritis Knee

Currently open trials in the same condition.

Other University of Pecs trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04270253.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing